GGrantIndex
Sort

51,593 grants matching hepatitis

The Genetics of Disease Progression and Treatment Response in Hepatitis C

$389,594
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Therapeutic Development of RNAi-based inhibitors against the Hepatitis Delta Viru

$389,582
Brian H. Johnston · Somagenics, Inc. · R43 · FY2014 · AI

Epigenetic Regulation of HBV cccDNA Transcription

$389,570
Haitao Guo · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI

Investigation of management and disease manifestations of viral hepatitis

$389,542
Theo Heller · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK

Structure Function Relationship of Human Apolipoprotein B100

$389,530
Nassrin Dashti · University Of Alabama At Birmingham · R01 · FY2015 · HL

Role of heat shock protein 90 in alcoholic liver disease

$389,500
Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · AA

Longitudinal cohort of newly acquired HCV infection

$389,499
Natl Centre/Hiv Epidemiology/Clncl Res · R01 · FY2005 · DA

Cytokine-stimulated systemic defenses during pneumococcal pneumonia

$389,480
Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2013 · HL

Risk Factors for AIDS among Drug Users: Getting Close to Zero

$389,480
Don C Des Jarlais · New York University · R01 · FY2018 · DA

Elucidating Vascular Neuropilin 1 (NRP1) Functions in Response to Novel Interactions with Insulin Substrates

$389,479
Ye Ding · Georgia State University · R01 · FY2021 · HL

Metabolism and Genetics of Hypobetalipoproteinemia

$389,443
Washington University · R01 · FY2005 · HL

CENTER FOR MEMBRANE TOXICITY STUDIES

$389,437
Mount Desert Island Biological Lab · P30 · FY2002 · ES

Optimized Metabolite Extraction, Separation, and Identification for Metabolomics

$389,426
Andrew Patterson · Pennsylvania State University, The · R01 · FY2015 · ES

Project 5: Phytorermediation of Pollutants Using Transgenic Plants

$389,305
Stuart E Strand · University Of Washington · P42 · FY2009 · ES

Studies of Inherited Causes of Fungal Susceptability

$389,291
Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Development of a novel and broadly applicable thermostable bacteriophage VLPs platforms for vaccine design, drug delivery, and imaging

$389,276
Ebenezer Tumban · Texas Tech University · R15 · FY2020 · AI

Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers

$389,273
Estella M Alonso · Lurie Children'S Hospital Of Chicago · U01 · FY2022 · DK

Novel markers for HCV-related HCC

$389,250
Fred Hutchinson Cancer Research Center · R01 · FY2004 · DK

The Role of Bacterial Choline Metabolism in Host Stress Responses

$389,246
Jonathan Mark Brown · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · DK

Atomic-Resolution Analysis of Translation Control

$389,229
Jamie H Cate · University Of California Berkeley · R01 · FY2014 · GM

Gene Therapy Clinical Candidate Development for Carbamoyl Phosphate Synthetase Deficiency

$389,215
Gerald S Lipshutz · University Of California Los Angeles · R61 · FY2022 · NS

Heat shock protein 90 in alcoholic liver disease: targeting macrophage function

$389,200
Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · AA

Lifetime Drinking Patterns & HCV Treatment Outcomes

$389,191
Marcia Russell · Pacific Institute For Res And Evaluation · R01 · FY2008 · AA

Role of SH2-B in Glucose Metabolism

$389,129
Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2009 · DK

Lipid transport in the intestine

$389,109
Judith Storch · Rutgers, The State Univ Of N.J. · R01 · FY2018 · DK